Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

EU-PFF NEWS

Article on “Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis” (2021)

02 Mar 2022 - 07:03

Share this

     

Frontiers in Medicine publishes Multinational European Survey.

President of EU-PFF Steve Jones and Jean-Michel Fourrier were co-authors of an article published in August 2021 about an online survey conducted among members of European patient organisations, with a self-reported diagnosis of Pulmonary Fibrosis. They were invited to participate in the survey, which assessed the diagnostic pathway retrospectively, focusing on four stages: (1) time from initial symptoms to first appointment in primary care; (2) time to hospital referral; (3) time to first hospital appointment; (4) time to final diagnosis. It comprised open-ended and closed questions focusing on time to diagnosis, factors contributing to delays, diagnostic tests, patient emotions, and information provision.

The survey shows that the time to diagnose Pulmonary Fibrosis varies widely across Europe and that delays occur at each stage of the diagnostic pathway. Raising awareness about pulmonary fibrosis amongst the general population and healthcare workers is essential to shorten the time to diagnosis. Furthermore, there remains a need to provide patients with sufficient information and support at all stages of their diagnostic journey.

Please find the full article here.

Related News & Events

New President Elected!

New President Elected!

The European Pulmonary Fibrosis Federation (EU-PFF) is pleased to announce the appointment of John...